Shares of Firefly Neuroscience, Inc. (AIFF) are surging roughly 43 percent on Friday morning trading following the announcement of discovery of new brain wave biomarkers for differential diagnosis of ADHD.
The company's shares are currently trading at $2.50 on the Nasdaq, up 43.97 percent. The stock opened at $1.9 and has climbed as high as $2.64 so far in today's session. Over the past year, it has traded in a range of $0.62 to $6.00.
With the company's AI-powered EEG/ERP technology, health experts could identify which ADHD subtype a patient has, which would help them to determine the most appropriate treatment type, inform dosage decisions, and potentially monitor whether an intervention is working.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.